US4223031A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Azolopyrimidinones
Assignee: Mead Johnson and Co LLC
•
Filing: 1978-05-05
•
Granted: 1980-09-16
•
Expires: 1998-05-05
Abstract
Abstract 6-(1H-Tetrazol-5-yl)thiozolo[3,2-a]pyrimidin-5-ones, 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-ones, and the corresponding imidazo- and triazolo-pyrimidines, thiones, and imines are useful as antiallergy and antiasthmatic compounds by virtue of their inhibitory action on the immediate hypersensitivity reaction in mammals and relaxant action on the tracheal muscle. Intermediates in the synthesis of these substances from 2-aminoazoles and ethoxy-methylene malononitrile also have smooth muscle relaxant and immediate hypersensitivity reaction inhibitory activity.
Inventors
- 👤 Robert R. Covington
- 👤 Davis L. Temple, Jr.
- 👤 Joseph P. Yevich
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 16:44
CPC Classifications
C; C07; C07D; C07D277/00; C07D277/60; A; A61; A61P; A61P11/00; A61P11/08; A61P37/00; A61P37/08; C07D235/00; C07D235/02; C07D235/04; C07D235/24; C07D235/30; C07D249/00; C07D249/02; C07D249/08; C07D249/10; C07D249/14; C07D277/02; C07D277/20; C07D277/32; C07D277/38; C07D277/42; C07D277/62; C07D277/68; C07D277/82; C07D487/00; C07D487/02; C07D487/04; C07D513/00; C07D513/02; C07D513/04
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
157 words
The 5H-thiazolo[3,2-a]pyrimidine having the following formula and the salts thereof with pharamaceutically acceptable bases ##STR9## wherein R 2 and R 3 are independently selected from H, the substituent A, or taken together with the carbon atoms to which they are attached denote cycloalkenyl having 5 to 7 ring members and up to 2 ring substituents, benzo, monosubstituted benzo, or di-substituted benzo wherein said substituents are independently defined by A, and A is selected from the group consisting of alkyl, alkenyl, alkynyl, alkoxy, alkenoxy, alkanoyl, alkenoyl, alkylsulfonyl, alkylsulfinyl, alkylthio, alkanoamido, cycloalkyl having 3 to 6 ring members and 1 to 3 optional alkyl substituents, cycloalkylalkyl having 3 to 6 ring members and 1 to 3 optional alkyl substituents, wherein each of the foregoing groups has up to 8 carbon atoms, phenyl, phenylmethyl, trifluoromethyl, nitro, amino, hydroxyl, halogen, carbamoyl, cyano, and cyanoalkyl having from 2 to 4 carbon atoms; Tet is 1H-tetrazol-5-yl; and Z is O, S, or NH.
Claim 2
Dependent Claim
157 words
The 5H-thiazolo[3,2-a]pyrimidine having the following formula and the salts thereof with pharamaceutically acceptable bases ##STR9## wherein R 2 and R 3 are independently selected from H, the substituent A, or taken together with the carbon atoms to which they are attached denote cycloalkenyl having 5 to 7 ring members and up to 2 ring substituents, benzo, monosubstituted benzo, or di-substituted benzo wherein said substituents are independently defined by A, and A is selected from the group consisting of alkyl, alkenyl, alkynyl, alkoxy, alkenoxy, alkanoyl, alkenoyl, alkylsulfonyl, alkylsulfinyl, alkylthio, alkanoamido, cycloalkyl having 3 to 6 ring members and 1 to 3 optional alkyl substituents, cycloalkylalkyl having 3 to 6 ring members and 1 to 3 optional alkyl substituents, wherein each of the foregoing groups has up to 8 carbon atoms, phenyl, phenylmethyl, trifluoromethyl, nitro, amino, hydroxyl, halogen, carbamoyl, cyano, and cyanoalkyl having from 2 to 4 carbon atoms; Tet is 1H-tetrazol-5-yl; and Z is O, S, or NH.
Claim 3
Dependent Claim
9 words
The compound of claim 1 wherein Z is O.
Claim 4
Dependent Claim
26 words
The compound of claim 1 wherein R 2 and R 3 are independently selected from H and A wherein A is as defined in claim 1.
Claim 5
Dependent Claim
6 words
The compound of claim 3, 3-methyl-6-(1H-tetrazol-5-yl)-5H-thiazolo[3,2-a]pyrimidin-5-one.
Claim 6
Dependent Claim
6 words
The compound of claim 3, 6-(1H-tetrazol-5-yl)-5H-thiazolo[3,2-a]pyrimidin-5-imine.
Claim 7
Dependent Claim
6 words
The compound of claim 3, 6-(1H-tetrazol-5-yl)-5H-thiazolo[3,2-a]pyrimidin-5-one.
Claim 8
Dependent Claim
6 words
The compound of claim 3, 3-phenyl-6-(1H-tetrazol-5-yl)-5H-thiazolo[3,2-a]pyrimidin-5-one.
Claim 9
Dependent Claim
44 words
The 4H-pyrimido[2,1-b]benzothiazole of claim 1 having the following formula and the salts thereof with pharmaceutically acceptable bases ##STR10## wherein R 7 and R 8 are independently selected from H and the substituent A, and A, Tet, and Z are as defined in claim 8.
Claim 10
Dependent Claim
9 words
The compound of claim 8 wherein Z is O.
Claim 11
Dependent Claim
6 words
The compound of claim 8, 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-one.
Claim 12
Dependent Claim
8 words
The compound of claim 8, 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-one potassium salt.
Claim 13
Dependent Claim
6 words
The compound of claim 8, 8-methoxy-3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-one.
Claim 14
Dependent Claim
6 words
The compound of claim 8, 7,8-dimethyl-3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-one.
Claim 15
Dependent Claim
6 words
The compound of claim 8, 7,9-dimethyl-3-(1H-tetrazol-5yl)-4H-pyrimido[2,1-b]benzothiazol-4-one.
Claim 16
Dependent Claim
6 words
The compound of claim 8, 8-nitro-3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-one.
Claim 17
Dependent Claim
6 words
The compound of claim 8, 3-(1H-tetrazol-5-yl)-4H-pyrimido[2,1-b]benzothiazol-4-imine.
Claim 18
Dependent Claim
32 words
The method for inhibiting the immediate hypersensitivity reaction in a sensitive mammal which comprises administering to said mammal a non-toxic effective hypersensitivity reaction inhibiting dose of a compound claimed in claim 8.
Claim 19
Dependent Claim
28 words
The method for relieving bronchospasm in a mammal suffering therefrom which comprises administering to said mammal a non-toxic bronchodilator effective dose of a compound claimed in claim 8.
References Cited (Backward Citations)
US3538086A
Cited
US3689488A
Cited
US3888983A
Cited
US4033961A
Cited
US4083980A
Cited
US4041163A
Cited
US4072679A
Cited
US4122274A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-09-16 | 1984-03-17 | 1984-09-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-09-16 | 1988-03-17 | 1988-09-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-09-16 | 1992-03-17 | 1992-09-16 | $7700.00 | Window Closed / Lapsed |